BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3900886)

  • 1. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
    Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
    Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
    Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
    Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
    Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
    Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CA 19-9 in early cancers of the bronchi. Comparison with the carcinoembryogenic antigen].
    Vindimian M; Lafitte JJ; Wattre P
    Biomed Pharmacother; 1987; 41(4):191-5. PubMed ID: 3476162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
    Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
    Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
    Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
    Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor-associated antigens in bronchial cancer].
    Gropp C
    Fortschr Med; 1982 Jun; 100(23):1100-7. PubMed ID: 6286437
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
    Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
    Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma].
    Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Libertucci D; Coni F; Oliaro A
    Minerva Med; 1987 Mar; 78(6):373-5. PubMed ID: 3470632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoembryonic antigen (CEA) in the blood serum of patients with bronchogenic carcinoma and selected diseases of the respiratory tract].
    Szklarz E; Gawlikowski W
    Pneumonol Pol; 1989 Apr; 57(4):217-21. PubMed ID: 2628950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
    Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
    Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.